DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20203658

Rare presentation of mycoplasma pneumonia: a case report

Bhimana Vaishnavi, Lalitha Janakiraman, K. Dhanalakshmi

Abstract


Mycoplasma is a frequent cause of community acquired pneumonia in children accounting for 20 percent of the cases. Though CNS complications are the most common extra pulmonary manifestations of M. pneumoniae stroke is a rare entity. Here we report a case of 7 years old male child with macrolide resistant M. pneumoniae complicated pneumonia that developed right hemiparesis and dysphasia. Brain magnetic resonance imaging and angiography showed left fronto parietal infarct and left carotid artery stenosis. He responed to non-macrolide antimicrobial regimen. This potential yet rare complication should be considered and closely monitored for in children presenting with complicated pneumonia.


Keywords


Mycoplasma pneumoniae, Stroke, Complicated pneumoniae

Full Text:

PDF

References


Mejias A, Ramilo O. Mycoplasma Pneumoniae. In: Kliegman RM, Behrman RE, Stanton BF, St. Geme J, Schor N, editors. Nelson Textbook of Pediatrics. 20th ed., Philadelphia: Saunders; 2016:1487-90.

Sanchez PJ. Mycoplasma and ureaplasma infections. In: Feigin, Cherry. Pediatric Infectious Disease. 5th ed. Philadelphia: Saunders;913-9.

Guleria R, Nisar N, Chawla T, Biswas N. Mycoplasma pneumoniae and central nervous system complications: A review. Journal of Laboratory and Clinical Medicine. 2005;146(2):55-63.

Fu M, Wong KS, Wynnie W, Gary ML, WongWK, et al. Middle cerbral artery occlusion after recent mycoplasma infection. Journal of Neurological Sciences. 1998;(157):113-5.

Patra PK , Arun Babu T. Unusual complication of Mycoplasma pneumonia in a five-year-old child. AMJ. 2016;6(2):73-4.

Jin X, Zou Y, Zhai J, Liu J, Huang B. Refractory Mycoplasma pneumoniae pneumonia with concomitant acute cerebral infarction in a child. Medicine. 2018;97(13):e0103.

Mélé N, Turc G. Stroke associated with recent mycoplasma pneumoniae infection: a systematic review of clinical features and presumed pathophysiological mechanisms. Front. Neurol. 2018;9:1109.

Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7: 974.

Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D,et al. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis. 2010; 67:355-8.

Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive mycoplasma pneumoniae pneumonia. Antimicrobial Agents and Chemotherapy. 2013;58(2):1034-8.